Bioventus (BVS)
NASDAQ:BVS
US Market
Holding BVS?
Track your performance easily

Bioventus (BVS) Financial Statements

160 Followers

Bioventus Financial Overview

Bioventus's market cap is currently ―. The company's EPS TTM is $-0.659; its P/E ratio is -20.79; Bioventus is scheduled to report earnings on November 5, 2024, and the estimated EPS forecast is $0.02. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 151.22M$ 129.46M$ 135.42M$ 120.79M$ 137.07M
Gross Profit$ 103.64M$ 88.38M$ 86.30M$ 78.85M$ 89.12M
EBIT$ -39.23M$ -4.85M$ -8.18M$ -7.96M$ -4.12M
EBITDA$ -26.14M$ 6.93M$ 4.29M$ 5.87M$ 10.48M
Net Income Common Stockholders$ -23.99M$ -4.57M$ -6.10M$ -7.30M$ -3.68M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 31.99M$ 25.17M$ 36.96M$ 26.83M$ 29.39M
Total Assets$ 792.17M$ 794.24M$ 810.91M$ 811.10M$ 836.96M
Total Debt$ 383.28M$ 391.24M$ 394.85M$ 394.62M$ 385.89M
Net Debt$ 351.29M$ 366.07M$ 357.88M$ 367.79M$ 356.50M
Total Liabilities$ 603.11M$ 576.81M$ 589.79M$ 584.65M$ 603.62M
Stockholders Equity$ 150.92M$ 171.28M$ 173.59M$ 177.53M$ 183.18M
Cash Flow-
Free Cash Flow$ 15.09M$ -6.30M$ 10.01M$ -10.35M$ 9.40M
Operating Cash Flow$ 15.16M$ -6.00M$ 10.37M$ -8.31M$ 10.79M
Investing Cash Flow$ -77.00K$ -1.00M$ -591.00K$ -2.04M$ 45.01M
Financing Cash Flow$ -7.84M$ -4.24M$ -14.00K$ 8.23M$ -62.25M
Currency in USD

Bioventus Earnings and Revenue History

Bioventus Debt to Assets

Bioventus Cash Flow

Bioventus Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis